Trifluridine, Tipiracil

• Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus … Recruiting
  2024-520356-24-00 Phase II 5 countries Delcath Systems Inc.
• PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with … Recruiting
  2023-505046-26-00 Phase III 1 country Centre Hospitalier Universitaire De Dijon
• Safety of Trifluridine/tipiracil in patients with dihydropyrimidine dehydrogenase deficiency diagnosed with metastatic colorectal or gastroe… Recruiting
  2023-508724-35-00 Phase II 1 country Unicancer
• Oxaliplatin ± nivolumab in combination with trifluridine/tipiracil or 5- fluorouracile ± nivolumab in frail patients with advanced, recurren… Recruiting
  2024-512999-35-00 Phase II 1 country Unicancer
• A trial to learn how well AZD0901 works and how safe it is compared to standard cancer treatments in adults with advanced and metastatic gas… Ended
  2023-508276-11-00 Phase III 5 countries AstraZeneca AB
• Clinical study to investigate efficacy of Botensilimab (AGEN1181) as Monotherapy and in Combination with Balstilimab (AGEN2034) or Investiga… Ended
  2022-502065-23-00 Phase II 4 countries Agenus Inc.
• A randomized, open label, multicenter phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic, refractory col… Ended
  2023-509771-17-00 Phase II/III 1 country Universitaetsklinikum Heidelberg AöR
• Clinical trial of MK-4280A for colorectal cancer that has spread after previous treatment Ended
  2024-511043-25-00 Phase III 4 countries Merck Sharp & Dohme LLC

Showing 1–8 of 8 trials